Showing results (581-590 of 1,005) with videos related to
Sort By:
Pageof 101
Ejhaem|August 21, 2023
Vidjil add-on for MRD quantification of samples processed using the EuroClonality-NGS protocolGuilherme Navarro Nilo Giusti, Antonio Vítor Ribeiro, Patrícia Yoshioka Jotta, et al.Ejhaem|August 21, 2023
The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR)Kenneth Jc Lim, Cameron Wellard, Dipti Talaulikar, et al.Ejhaem|August 21, 2023
Haploidentical hematopoietic cell transplant recipient presents with late-onset Epstein Barr virus-associated posttransplant lymphoproliferative disorderAdam Braun, Lawrence Liu, Monzr M Al Malki, et al.Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.Ejhaem|August 21, 2023
Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopeniaHiroya Ichikawa, Kimikazu Yakushijin, Yoshiharu Miyata, et al.Ejhaem|August 21, 2023
Incidence of blast phase in myelofibrosis according to anemia severityBarbara Mora, Margherita Maffioli, Elisa Rumi, et al.Ejhaem|August 21, 2023
Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphomaYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.Ejhaem|August 21, 2023
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessationRebecca W Silbermann, Timothy Martin Schmidt, Susan Bal, et al.Ejhaem|August 21, 2023
Administration of combined venetoclax and azacitidine in a patient with acute myeloid leukemia and multiple comorbidities undergoing dialysis: A case reportYuina Akagi, Yusuke Yamashita, Hideki Kosako, et al.Ejhaem|August 21, 2023
T-cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directionsChloe O'Neill, Niels W C J van de DonkPageof 101